These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12651870)

  • 1. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.
    Taylor JP; Tanaka F; Robitschek J; Sandoval CM; Taye A; Markovic-Plese S; Fischbeck KH
    Hum Mol Genet; 2003 Apr; 12(7):749-57. PubMed ID: 12651870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggresomes: a cellular response to misfolded proteins.
    Johnston JA; Ward CL; Kopito RR
    J Cell Biol; 1998 Dec; 143(7):1883-98. PubMed ID: 9864362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role for autophagy in the removal of aggresomes in Schwann cells.
    Fortun J; Dunn WA; Joy S; Li J; Notterpek L
    J Neurosci; 2003 Nov; 23(33):10672-80. PubMed ID: 14627652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis.
    Lu M; Boschetti C; Tunnacliffe A
    J Biol Chem; 2015 Nov; 290(46):27986-8000. PubMed ID: 26408200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenilin-binding protein forms aggresomes in monkey kidney COS-7 cells.
    Namekata K; Nishimura N; Kimura H
    J Neurochem; 2002 Aug; 82(4):819-27. PubMed ID: 12358787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations.
    Ryan MC; Shooter EM; Notterpek L
    Neurobiol Dis; 2002 Jul; 10(2):109-18. PubMed ID: 12127149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera.
    García-Mata R; Bebök Z; Sorscher EJ; Sztul ES
    J Cell Biol; 1999 Sep; 146(6):1239-54. PubMed ID: 10491388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
    Waelter S; Boeddrich A; Lurz R; Scherzinger E; Lueder G; Lehrach H; Wanker EE
    Mol Biol Cell; 2001 May; 12(5):1393-407. PubMed ID: 11359930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation.
    Saliba RS; Munro PM; Luthert PJ; Cheetham ME
    J Cell Sci; 2002 Jul; 115(Pt 14):2907-18. PubMed ID: 12082151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases.
    Webb JL; Ravikumar B; Rubinsztein DC
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2541-50. PubMed ID: 15325591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
    Ben-Gedalya T; Lyakhovetsky R; Yedidia Y; Bejerano-Sagie M; Kogan NM; Karpuj MV; Kaganovich D; Cohen E
    J Cell Sci; 2011 Jun; 124(Pt 11):1891-902. PubMed ID: 21558416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.
    Mandrusiak LM; Beitel LK; Wang X; Scanlon TC; Chevalier-Larsen E; Merry DE; Trifiro MA
    Hum Mol Genet; 2003 Jul; 12(13):1497-506. PubMed ID: 12812978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-negative effect of mutant valosin-containing protein in aggresome formation.
    Kitami MI; Kitami T; Nagahama M; Tagaya M; Hori S; Kakizuka A; Mizuno Y; Hattori N
    FEBS Lett; 2006 Jan; 580(2):474-8. PubMed ID: 16386250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of surfactant protein C: characterization of aggresome formation by EGFP chimeras containing propeptide mutants lacking conserved cysteine residues.
    Kabore AF; Wang WJ; Russo SJ; Beers MF
    J Cell Sci; 2001 Jan; 114(Pt 2):293-302. PubMed ID: 11148131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance.
    Yung C; Sha D; Li L; Chin LS
    Mol Neurobiol; 2016 Nov; 53(9):6270-6287. PubMed ID: 26563499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway.
    Olzmann JA; Chin LS
    Autophagy; 2008 Jan; 4(1):85-7. PubMed ID: 17957134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
    Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
    Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggresome formation and neurodegenerative diseases: therapeutic implications.
    Olzmann JA; Li L; Chin LS
    Curr Med Chem; 2008; 15(1):47-60. PubMed ID: 18220762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hook2 contributes to aggresome formation.
    Szebenyi G; Wigley WC; Hall B; Didier A; Yu M; Thomas P; Krämer H
    BMC Cell Biol; 2007 May; 8():19. PubMed ID: 17540036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.